TrialNature medicine2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
Franco Locatelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
TrialNature medicine2025
Franco Locatelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.